These findings not only provide mechanistic insights into the role of ISM in promoting adipose browning but also highlight the Gnas-cAMP-AMPK axis as a potential pathway for developing new compounds to treat metabolic disorders, such as obesity. This evidence concerns the gene GNAS and metabolic disease.